ACADIA Pharmaceuticals Statistics
NASDAQ: ACADHealth CareBiotechnology: Pharmaceutical PreparationsUSD
17.11-0.48 (-2.73%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ACADIA Pharmaceuticals by the numbers
ACADIA Pharmaceuticals has a market capitalization of $2.96 billion based on 172.83M shares outstanding. Its trailing P/E ratio is 8.1, and its forward P/E is 15.8. The stock trades 17.7% below its 50-day average and 26.1% below its 200-day average.
Average daily trading volume is 2.18M shares, or about $37.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ACAD valuation vs. peer median
| Metric | ACAD | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.96B | $3.02B | -2% |
| Forward P/E | 15.8 | 28.9 | -45% |
| Avg. volume | 2.18M | 3.05M | -28% |
Peer median across 8 companies: LEGN, DYN, TLX, BHC, XERS, SLS, VKTX, ABCL.
Valuation
- Market cap
- $2.96B
- P/E (TTM)
- 8.07
- Forward P/E
- 15.75
- Price / sales (latest FY)
- 2.76
- EPS (TTM)
- $2.12
- Shares outstanding
- 172.83M
Price and trading
- Previous close
- 17.59
- Open
- 17.47
- Day range
- 17.05 – 17.79
- 52-week range
- 15.86 – 30.96
- 52-week change
- -27.38%
- Beta
- —
- Volume
- 1.90M
- Average volume
- 2.18M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 2.96B
- Pe
- 8.07
- Forward Pe
- 15.75
- Eps
- 2.12
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 30.96
- Week52 Low
- 15.86
- Avg Volume
- 2.18M
- Shares Outstanding
- 172.83M
- Ma50
- 20.80
- Ma200
- 23.16
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -44.74%
- Pct From52w Low
- 7.88%